GLO1 and hepatocellular carcinoma: The use of BrBzGSHCp2 has been proven to be effective both in vitro and in vivo models where Glo1 is expressed at high levels, as demonstrated in lung cancer cell line and mouse model (82), in drug resistant leukemia cells (83) and in Huh7 HCC cell line (84).